TMO Stock Analysis: Buy, Sell, or Hold?
TMO - Thermo Fisher Scientific, Inc.
$478.99
5.63 (1.19%)
▲
5d:
+0.18%
30d:
-8.08%
90d:
-17.52%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Apr 22, 2026
22d
Smart Money Accumulation
TMO is down 8.2% this week, but smart money is accumulating calls. Top strike: $500 2026-04-17 with 118 OI. Call ratio: 99% View Scanner →
Strength: 9.0/10
Get Alerted When TMO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TMO trading at deep discount. Market pricing in -6.6% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: TMO trading at deep discount. Market pricing in -6.6% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$806.38
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$500.70
4.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TMO is currently trading at $478.99, which is considered oversold relative to its 30-day fair value range of $477.65 to $515.30. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.6) compared to its historical average (21.6). Remarkably, the market is currently pricing in an annual earnings decline of 6.6% over the next few years. This pessimistic expectation contrasts with the company's recent 9.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, TMO is in a strong uptrend. Immediate support is located at $458.34, while resistance sits at $499.95.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $663.96 (+40.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TMO is in a strong uptrend. Immediate support is located at $458.34, while resistance sits at $499.95.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $663.96 (+40.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$477.65 -
$515.30
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 40.3% below Wall St target ($663.96)
Fair Price Analysis
30-Day Fair Range
$477.65 -
$515.30
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$458.34
Resistance Level
$499.95
Current Trend
Strong Uptrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.60
Wall Street Target
$663.96
(+40.3%)
Revenue Growth (YoY)
7.2%
Earnings Growth (YoY)
9.3%
Profit Margin
15.0%
Valuation Discount vs History
-6.6% cheaper
PE vs Historical
17.6 vs 21.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.6%
(market-implied from PE analysis)
1-Year Target
$442.12
(-7%)
2-Year Target
$412.94
(-13%)
3-Year Target
$385.68
(-19%)
3-Yr Target (if PE normalizes)
(PE: 18→22)
$473.26
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 9.6%)
$794.05
(+68%)
Base:
(SPY PE: 17.6, Growth: 9.6%)
$624.00
(+32%)
Bear:
(PE: 15.0, Growth: 9.6%)
$530.40
(+12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 26.74 | Current EPS (TTM): $17.74
Bull Case
$791.00
(+65%)
Analyst growth 51.6%, PE expands to 29.4
Base Case
$719.09
(+50%)
Market implied 51.6%, PE stable at 26.7
Bear Case
$322.59
(-33%)
Severe decline -20.0%, PE contracts to 22.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.6 to 21.6
Stabilization Target:
$580.84
(+22.7%)
PE Expansion Potential:
+22.7%
Share & Embed Analysis
Last updated: March 30, 2026 10:27 AM ET
Data refreshes hourly during market hours. Next update: 11:27 AM
Data refreshes hourly during market hours. Next update: 11:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TMO showing a specific setup today?
Insider Activity (6 Months)
4
Buys
16
Sells
Net
INSIDERS SELLING
Recent Transactions
Marc N Casper
SELL
5000 shares
2026-03-04
Ro Khanna
BUY
2026-02-24
Gianluca Pettiti
SELL
400 shares
2026-02-09
Featured in Portfolios
TMO is a key holding in these high-performance investment strategies.
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 58 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 60 HOLD |
|
IQV
IQVIA Holdings Inc |
BUY
23 analysts |
$236 | 58 HOLD |
Advanced TMO Option Strategies
Professional options setups generated by AI based on today's TMO price and gamma walls.
